MedX Health Corp (V:MDX) — Market Cap & Net Worth
Market Cap & Net Worth: MedX Health Corp (MDX)
MedX Health Corp (V:MDX) has a market capitalization of $13.05 Million (CA$18.04 Million) as of September 24, 2026. Listed on the V stock exchange, this Canada-based company holds position #26474 globally and #1069 in its home market, demonstrating a 10.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MedX Health Corp's stock price CA$0.06 by its total outstanding shares 327932315 (327.93 Million). Also see MedX Health Corp asset portfolio for a full breakdown of the balance sheet.
MedX Health Corp Market Cap History: 2015 to 2026
MedX Health Corp's market capitalization history from 2015 to 2026. Data shows change from $17.79 Million to $13.05 Million (-4.41% CAGR). Also see MDX cash flow metrics for how efficiently the company converts equity into cash flow.
MedX Health Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MedX Health Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check MDX stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
29.07x
MedX Health Corp's market cap is 29.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $17.79 Million | $1.17 Million | -$499.25K | 15.19x | N/A |
| 2016 | $45.07 Million | $817.05K | -$1.34 Million | 55.16x | N/A |
| 2017 | $24.91 Million | $1.09 Million | -$1.60 Million | 22.78x | N/A |
| 2018 | $33.21 Million | $1.09 Million | -$4.19 Million | 30.54x | N/A |
| 2019 | $30.84 Million | $860.25K | -$3.28 Million | 35.85x | N/A |
| 2020 | $28.47 Million | $530.07K | -$3.20 Million | 53.70x | N/A |
| 2021 | $18.98 Million | $563.10K | -$5.32 Million | 33.70x | N/A |
| 2022 | $9.49 Million | $510.61K | -$5.13 Million | 18.58x | N/A |
| 2023 | $14.23 Million | $456.09K | -$4.58 Million | 31.21x | N/A |
| 2024 | $14.23 Million | $489.70K | -$3.65 Million | 29.07x | N/A |
Competitor Companies of MDX by Market Capitalization
Companies near MedX Health Corp in the global market cap rankings as of September 24, 2026. Explore MDX net asset momentum to track how rapidly the company is growing its equity base year over year.
Key companies related to MedX Health Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #122 globally with a market cap of $180.30 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #237 globally with a market cap of $105.52 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #122 | Abbott Laboratories | NYSE:ABT | $180.30 Billion | $103.69 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $90.77 |
| #237 | Stryker Corporation | NYSE:SYK | $105.52 Billion | $275.09 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
MedX Health Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, MedX Health Corp's market cap moved from $17.79 Million to $ 13.05 Million, with a yearly change of -4.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$13.05 Million | -8.33% |
| 2025 | CA$14.23 Million | 0.00% |
| 2024 | CA$14.23 Million | 0.00% |
| 2023 | CA$14.23 Million | +50.00% |
| 2022 | CA$9.49 Million | -50.00% |
| 2021 | CA$18.98 Million | -33.33% |
| 2020 | CA$28.47 Million | -7.69% |
| 2019 | CA$30.84 Million | -7.14% |
| 2018 | CA$33.21 Million | +33.33% |
| 2017 | CA$24.91 Million | -44.74% |
| 2016 | CA$45.07 Million | +153.33% |
| 2015 | CA$17.79 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of MedX Health Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.05 Million USD |
| MoneyControl | $13.05 Million USD |
| MarketWatch | $13.05 Million USD |
| marketcap.company | $13.05 Million USD |
| Reuters | $13.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MedX Health Corp
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED … Read more